Literature DB >> 15252624

A new [2 + 1] mixed ligand concept based on [99(m)Tc(OH2)3(CO)3]+: a basic study.

Stefan Mundwiler1, Monika Kündig, Kirstin Ortner, Roger Alberto.   

Abstract

Mixed ligand fac-tricarbonyl complexes of the general formula [M(L1)(L2)(CO)3](M = Re, 99(m)Tc, L1= imidazole, benzyl isocyanide, L2 = 1H-imidazole-4-carboxylic acid, pyridine-2,4-dicarboxylic acid, pyridine-2,5-dicarboxylic acid) have been prepared starting from the precursors [M(OH2)3(CO)3]+. The complexes can be obtained in good yield and purity in a two-step procedure by first attaching the bidentate ligand followed by addition of the monodentate. 99mTc compounds can also be prepared at the tracer level in one-pot procedures with L1 and L2 being concomitantly present. This [2 + 1] approach allows the labeling of bioactive molecules containing a monodentate or a bidentate donor site. Examples given in here are N-(tert-butoxycarbonyl)glycyl-N-(3-(imidazol-1-yl)propyl)phenylalaninamide, 5-((3-(imidazol-1-yl)propyl)aminomethyl)-2'-deoxyuridine and 4-(5-isonitrilpentyl)-1-(2-methoxyphenyl)-piperazine as L1 and N-((6-carboxypyridine-3-yl)methyl)glycylphenylalanine as L2. The corresponding second ligand can be used to influence the physico-chemical properties of the conjugate. The crystal structures of [99Tc(OH2)(imc)(CO)3], [Re(OH2)(2,4-dipic)(CO)3], [Re(bic)(2,4-dipic)(CO)3] and [Re(im)(2,5-dipic)(CO)3] are reported.

Entities:  

Year:  2004        PMID: 15252624     DOI: 10.1039/b400220b

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  15 in total

1.  Influence of bidentate ligand donor types on the formation and stability in 2 + 1 fac-[MI(CO)3]+ (M = Re, 99mTc) complexes.

Authors:  Thomas R Hayes; Shalina C Bottorff; Winston S Slocumb; Charles L Barnes; Aurora E Clark; Paul D Benny
Journal:  Dalton Trans       Date:  2017-01-24       Impact factor: 4.390

2.  Design and synthesis of a bombesin peptide-conjugated tripodal phosphino dithioether ligand topology for the stabilization of the fac-[M(CO)3]+ core (M=(99 m)Tc or Re).

Authors:  Raghuraman Kannan; Nagavarakishore Pillarsetty; Hariprasad Gali; Timothy J Hoffman; Charles L Barnes; Silvia S Jurisson; Charles J Smith; Wynn A Volkert
Journal:  Inorg Chem       Date:  2011-05-18       Impact factor: 5.165

3.  Aqua-tricarbon-yl(3,5,7-tribromo-tropolonato)rhenium(I) methanol solvate.

Authors:  Marietjie Schutte; Hendrik G Visser; Andreas Roodt
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-11-22

4.  [N,N-Bis(diphenyl-phosphino)propyl-amine-κP,P]bromidotricarbonyl-rhenium(I).

Authors:  Marietjie Schutte; Hendrik G Visser; Alice Brink
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-11-14

5.  Tetra-ethyl-ammonium tricarbonyl-chlorido-(pyrazine-2-carboxyl-ato-N,O)rhenate(I).

Authors:  Janine Suthiram; Kanyisa Mhlaba; Jan Rijn Zeevaart; Hendrik G Visser; Andreas Roodt
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-10-17

6.  Tetra-ethyl-ammonium bromidotricarbon-yl(tropolonato)rhenate(I).

Authors:  Marietjie Schutte; Hendrik G Visser; Andreas Roodt
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-06-26

7.  Tetra-ethyl-ammonium (acetyl-acetonato)bromidotricarbonyl-rhenate(I).

Authors:  Alice Brink; Hendrik G Visser; Andreas Roodt
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-12-04

8.  Tetra-ethyl-ammonium tricarbonyl-chlorido(quinoxaline-2-carboxyl-ato-κN,O)rhenate(I).

Authors:  Janine Suthiram; Jan Rijn Zeevaart; Hendrik G Visser; Andreas Roodt
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-07-31

9.  Aqua-tricarbon-yl(4-carboxy-pyridine-2-carboxyl-ato-κN,O)rhenium(I).

Authors:  Marietjie Schutte; Hendrik G Visser
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-09-06

10.  Tetra-ethyl-ammonium dibromido-tricarbon-yl(o-toluidine)rhenate(I).

Authors:  Alice Brink; Hendrik G Visser; Andreas Roodt
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.